Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

172 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical applications of natural killer T cell-based immunotherapy for cancer.
Motohashi S, Nakayama T. Motohashi S, et al. Cancer Sci. 2008 Apr;99(4):638-45. doi: 10.1111/j.1349-7006.2008.00730.x. Epub 2008 Feb 21. Cancer Sci. 2008. PMID: 18294290 Review.
Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients.
Iizasa T, Fujisawa T, Suzuki M, Motohashi S, Yasufuku K, Yasukawa T, Baba M, Shiba M. Iizasa T, et al. Among authors: motohashi s. Clin Cancer Res. 1999 Jan;5(1):149-53. Clin Cancer Res. 1999. PMID: 9918213
Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells.
Kawano T, Nakayama T, Kamada N, Kaneko Y, Harada M, Ogura N, Akutsu Y, Motohashi S, Iizasa T, Endo H, Fujisawa T, Shinkai H, Taniguchi M. Kawano T, et al. Among authors: motohashi s. Cancer Res. 1999 Oct 15;59(20):5102-5. Cancer Res. 1999. PMID: 10537282
Inhibition of tumor metastasis by adoptive transfer of IL-12-activated Valpha14 NKT cells.
Shin T, Nakayama T, Akutsu Y, Motohashi S, Shibata Y, Harada M, Kamada N, Shimizu C, Shimizu E, Saito T, Ochiai T, Taniguchi M. Shin T, et al. Among authors: motohashi s. Int J Cancer. 2001 Feb 15;91(4):523-8. doi: 10.1002/1097-0215(20010215)91:4<523::aid-ijc1087>3.0.co;2-l. Int J Cancer. 2001. PMID: 11251976
The role of alpha-galactosylceramide-activated Valpha14 natural killer T cells in the regulation of Th2 cell differentiation.
Nakayama T, Yamashita M, Kawano T, Shimizu C, Shibata Y, Kamata T, Kaneko Y, Kobayashi S, Takeda U, Motohashi S, Cui J, Taniguchi M. Nakayama T, et al. Among authors: motohashi s. Int Arch Allergy Immunol. 2001 Jan-Mar;124(1-3):38-42. doi: 10.1159/000053663. Int Arch Allergy Immunol. 2001. PMID: 11306921
Expansion of lung V alpha 14 NKT cells by administration of alpha-galactosylceramide-pulsed dendritic cells.
Akutsu Y, Nakayama T, Harada M, Kawano T, Motohashi S, Shimizu E, Ito T, Kamada N, Saito T, Matsubara H, Miyazawa Y, Ochiai T, Taniguchi M. Akutsu Y, et al. Among authors: motohashi s. Jpn J Cancer Res. 2002 Apr;93(4):397-403. doi: 10.1111/j.1349-7006.2002.tb01270.x. Jpn J Cancer Res. 2002. PMID: 11985789 Free PMC article.
Preserved IFN-alpha production of circulating Valpha24 NKT cells in primary lung cancer patients.
Motohashi S, Kobayashi S, Ito T, Magara KK, Mikuni O, Kamada N, Iizasa T, Nakayama T, Fujisawa T, Taniguchi M. Motohashi S, et al. Int J Cancer. 2002 Nov 10;102(2):159-65. doi: 10.1002/ijc.10678. Int J Cancer. 2002. PMID: 12385012
TH1-biased immunity induced by exposure to Antarctic winter.
Shirai T, Magara KK, Motohashi S, Yamashita M, Kimura M, Suwazomo Y, Nogawa K, Kuriyama T, Taniguchi M, Nakayama T. Shirai T, et al. Among authors: motohashi s. J Allergy Clin Immunol. 2003 Jun;111(6):1353-60. doi: 10.1067/mai.2003.1504. J Allergy Clin Immunol. 2003. PMID: 12789239
Impaired IFN-gamma production of Valpha24 NKT cells in non-remitting sarcoidosis.
Kobayashi S, Kaneko Y, Seino K, Yamada Y, Motohashi S, Koike J, Sugaya K, Kuriyama T, Asano S, Tsuda T, Wakao H, Harada M, Kojo S, Nakayama T, Taniguchi M. Kobayashi S, et al. Among authors: motohashi s. Int Immunol. 2004 Feb;16(2):215-22. doi: 10.1093/intimm/dxh020. Int Immunol. 2004. PMID: 14734606
Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer.
Yamaji H, Iizasa T, Koh E, Suzuki M, Otsuji M, Chang H, Motohashi S, Yokoi S, Hiroshima K, Tagawa M, Nakayama T, Fujisawa T. Yamaji H, et al. Among authors: motohashi s. Cancer Immunol Immunother. 2004 Sep;53(9):786-92. doi: 10.1007/s00262-004-0533-9. Epub 2004 Jun 4. Cancer Immunol Immunother. 2004. PMID: 15185009
172 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback